Target
Bromodomain-containing protein 4 [44-164]
Ligand
BDBM425397
Substrate
n/a
Meas. Tech.
Alphascreen Binding Assay
IC50
<1000±n/a nM
Citation
 Zhang, JBuell, JChan, KIbrahim, PNLin, JPham, PShi, SSpevak, WWu, GWu, J Heterocyclic compounds and uses thereof US Patent  US10519177 Publication Date 12/31/2019 
Target
Name:
Bromodomain-containing protein 4 [44-164]
Synonyms:
BRD4 | BRD4_HUMAN | Bromodomain-containing protein 4 (aa 44-164) | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14412.06
Organism:
Homo sapiens (Human)
Description:
BRD4-BD1 (44-164)
Residue:
121
Sequence:
NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINEL
  
Inhibitor
Name:
BDBM425397
Synonyms:
3-[6-(3,5-dimethylisoxazol-4-yl)-1-(1- phenylethyl)pyrrolo[3,2-b]pyridin-3- yl]prop-2-yn-1-ol | US10519177, Compound P-0302
Type:
Small organic molecule
Emp. Form.:
C23H21N3O2
Mol. Mass.:
371.4317
SMILES:
CC(c1ccccc1)n1cc(C#CCO)c2ncc(cc12)-c1c(C)noc1C
Structure:
Search PDB for entries with ligand similarity: